These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

197 related articles for article (PubMed ID: 22319575)

  • 21. Potential new mechanisms of placental damage in celiac disease: anti-transglutaminase antibodies impair human endometrial angiogenesis.
    Di Simone N; De Spirito M; Di Nicuolo F; Tersigni C; Castellani R; Silano M; Maulucci G; Papi M; Marana R; Scambia G; Gasbarrini A
    Biol Reprod; 2013 Oct; 89(4):88. PubMed ID: 23966323
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Unexpected role of surface transglutaminase type II in celiac disease.
    Maiuri L; Ciacci C; Ricciardelli I; Vacca L; Raia V; Rispo A; Griffin M; Issekutz T; Quaratino S; Londei M
    Gastroenterology; 2005 Nov; 129(5):1400-13. PubMed ID: 16285941
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Transglutaminase inhibitors attenuate vascular calcification in a preclinical model.
    Beazley KE; Banyard D; Lima F; Deasey SC; Nurminsky DI; Konoplyannikov M; Nurminskaya MV
    Arterioscler Thromb Vasc Biol; 2013 Jan; 33(1):43-51. PubMed ID: 23117658
    [TBL] [Abstract][Full Text] [Related]  

  • 24. β
    Vyas FS; Nelson CP; Freeman F; Boocock DJ; Hargreaves AJ; Dickenson JM
    Eur J Pharmacol; 2017 Oct; 813():105-121. PubMed ID: 28754379
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Transglutaminase 2 undergoes a large conformational change upon activation.
    Pinkas DM; Strop P; Brunger AT; Khosla C
    PLoS Biol; 2007 Dec; 5(12):e327. PubMed ID: 18092889
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Tissue Transglutaminase-Mediated AT1 Receptor Sensitization Underlies Pro-inflammatory Cytokine LIGHT-Induced Hypertension.
    Liu C; Luo R; Wang W; Peng Z; Johnson GVW; Kellems RE; Xia Y
    Am J Hypertens; 2019 Apr; 32(5):476-485. PubMed ID: 30715101
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Transglutaminase 2-targeted autoantibodies in celiac disease: Pathogenetic players in addition to diagnostic tools?
    Lindfors K; Mäki M; Kaukinen K
    Autoimmun Rev; 2010 Sep; 9(11):744-9. PubMed ID: 20547248
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Type 2 Transglutaminase in Coeliac Disease: A Key Player in Pathogenesis, Diagnosis and Therapy.
    Paolella G; Sposito S; Romanelli AM; Caputo I
    Int J Mol Sci; 2022 Jul; 23(14):. PubMed ID: 35886862
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Small-intestinal TG2-specific plasma cells at different stages of coeliac disease.
    Hietikko M; Koskinen O; Kurppa K; Laurila K; Saavalainen P; Salmi T; Ilus T; Huhtala H; Kaukinen K; Lindfors K
    BMC Immunol; 2018 Dec; 19(1):36. PubMed ID: 30522434
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Interferon-γ activates transglutaminase 2 via a phosphatidylinositol-3-kinase-dependent pathway: implications for celiac sprue therapy.
    Diraimondo TR; Klöck C; Khosla C
    J Pharmacol Exp Ther; 2012 Apr; 341(1):104-14. PubMed ID: 22228808
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Cardiac fibrosis can be attenuated by blocking the activity of transglutaminase 2 using a selective small-molecule inhibitor.
    Wang Z; Stuckey DJ; Murdoch CE; Camelliti P; Lip GYH; Griffin M
    Cell Death Dis; 2018 Apr; 9(6):613. PubMed ID: 29795262
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Enhanced B-Cell Receptor Recognition of the Autoantigen Transglutaminase 2 by Efficient Catalytic Self-Multimerization.
    Stamnaes J; Iversen R; du Pré MF; Chen X; Sollid LM
    PLoS One; 2015; 10(8):e0134922. PubMed ID: 26244572
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Tissue transglutaminase (TG2) is involved in the resistance of cancer cells to the histone deacetylase (HDAC) inhibitor vorinostat.
    Carbone C; Di Gennaro E; Piro G; Milone MR; Pucci B; Caraglia M; Budillon A
    Amino Acids; 2017 Mar; 49(3):517-528. PubMed ID: 27761756
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Cosilencing Intestinal Transglutaminase-2 and Interleukin-15 Using Gelatin-Based Nanoparticles in an in Vitro Model of Celiac Disease.
    Attarwala H; Clausen V; Chaturvedi P; Amiji MM
    Mol Pharm; 2017 Sep; 14(9):3036-3044. PubMed ID: 28737923
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Transglutaminase 2 is dispensable but required for the survival of mice in dextran sulfate sodium-induced colitis.
    Jeong EM; Son YH; Choi Y; Kim JH; Lee JH; Cho SY; Kim IG
    Exp Mol Med; 2016 Nov; 48(11):e267. PubMed ID: 27811936
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Epithelial transport and deamidation of gliadin peptides: a role for coeliac disease patient immunoglobulin A.
    Rauhavirta T; Qiao SW; Jiang Z; Myrsky E; Loponen J; Korponay-Szabó IR; Salovaara H; Garcia-Horsman JA; Venäläinen J; Männistö PT; Collighan R; Mongeot A; Griffin M; Mäki M; Kaukinen K; Lindfors K
    Clin Exp Immunol; 2011 Apr; 164(1):127-36. PubMed ID: 21235541
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Towards Celiac-safe foods: Decreasing the affinity of transglutaminase 2 for gliadin by addition of ascorbyl palmitate and ZnCl
    Engstrom N; Saenz-Méndez P; Scheers J; Scheers N
    Sci Rep; 2017 Mar; 7(1):77. PubMed ID: 28250436
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The Oral Transglutaminase 2 Inhibitor ZED1227 Accumulates in the Villous Enterocytes in Celiac Disease Patients during Gluten Challenge and Drug Treatment.
    Isola J; Mäki M; Hils M; Pasternack R; Viiri K; Dotsenko V; Montonen T; Zimmermann T; Mohrbacher R; Greinwald R; Schuppan D
    Int J Mol Sci; 2023 Jun; 24(13):. PubMed ID: 37445994
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The preferred substrates for transglutaminase 2 in a complex wheat gluten digest are Peptide fragments harboring celiac disease T-cell epitopes.
    Dørum S; Arntzen MØ; Qiao SW; Holm A; Koehler CJ; Thiede B; Sollid LM; Fleckenstein B
    PLoS One; 2010 Nov; 5(11):e14056. PubMed ID: 21124911
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Gα(h)/transglutaminase-2 activity is required for maximal activation of adenylylcyclase 8 in human and rat glioma cells.
    Obara Y; Yanagihata Y; Abe T; Dafik L; Ishii K; Nakahata N
    Cell Signal; 2013 Mar; 25(3):589-97. PubMed ID: 23200849
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.